112 related articles for article (PubMed ID: 16314052)
1. EVI1 and hematopoietic disorders: history and perspectives.
Nucifora G; Laricchia-Robbio L; Senyuk V
Gene; 2006 Mar; 368():1-11. PubMed ID: 16314052
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression.
Yuasa H; Oike Y; Iwama A; Nishikata I; Sugiyama D; Perkins A; Mucenski ML; Suda T; Morishita K
EMBO J; 2005 Jun; 24(11):1976-87. PubMed ID: 15889140
[TBL] [Abstract][Full Text] [Related]
3. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
[TBL] [Abstract][Full Text] [Related]
4. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
[TBL] [Abstract][Full Text] [Related]
5. Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.
Senyuk V; Sinha KK; Li D; Rinaldi CR; Yanamandra S; Nucifora G
Cancer Res; 2007 Jun; 67(12):5658-66. PubMed ID: 17575132
[TBL] [Abstract][Full Text] [Related]
6. Comparative expression analysis of the antagonistic transcription factors EVI1 and MDS1-EVI1 in murine tissues and during in vitro hematopoietic differentiation.
Wimmer K; Vinatzer U; Zwirn P; Fonatsch C; Wieser R
Biochem Biophys Res Commun; 1998 Nov; 252(3):691-6. PubMed ID: 9837768
[TBL] [Abstract][Full Text] [Related]
7. A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a.
Spensberger D; Delwel R
FEBS Lett; 2008 Aug; 582(18):2761-7. PubMed ID: 18619962
[TBL] [Abstract][Full Text] [Related]
8. [EVI1 and its role in myelodysplastic syndrome, myeloid leukemia and other malignant diseases].
Fuchs O
Cas Lek Cesk; 2006; 145(8):619-24. PubMed ID: 16995417
[TBL] [Abstract][Full Text] [Related]
9. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
10. Ecotropic viral integration site-1 is activated during, and is sufficient for, neuroectodermal P19 cell differentiation.
Kazama H; Kodera T; Shimizu S; Mizoguchi H; Morishita K
Cell Growth Differ; 1999 Aug; 10(8):565-73. PubMed ID: 10470856
[TBL] [Abstract][Full Text] [Related]
11. The role of EVI1 in normal and leukemic cells.
Buonamici S; Chakraborty S; Senyuk V; Nucifora G
Blood Cells Mol Dis; 2003; 31(2):206-12. PubMed ID: 12972028
[TBL] [Abstract][Full Text] [Related]
12. Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT.
Liu Y; Chen L; Ko TC; Fields AP; Thompson EA
Oncogene; 2006 Jun; 25(25):3565-75. PubMed ID: 16462766
[TBL] [Abstract][Full Text] [Related]
13. EVI1 Impairs myelopoiesis by deregulation of PU.1 function.
Laricchia-Robbio L; Premanand K; Rinaldi CR; Nucifora G
Cancer Res; 2009 Feb; 69(4):1633-42. PubMed ID: 19208846
[TBL] [Abstract][Full Text] [Related]
14. An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies.
Bobadilla D; Enriquez EL; Alvarez G; Gaytan P; Smith D; Slovak ML
Br J Haematol; 2007 Mar; 136(6):806-13. PubMed ID: 17341266
[TBL] [Abstract][Full Text] [Related]
15. EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression.
Cattaneo F; Nucifora G
J Cell Biochem; 2008 Oct; 105(2):344-52. PubMed ID: 18655152
[TBL] [Abstract][Full Text] [Related]
16. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
17. Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells.
Kustikova OS; Schwarzer A; Stahlhut M; Brugman MH; Neumann T; Yang M; Li Z; Schambach A; Heinz N; Gerdes S; Roeder I; Ha TC; Steinemann D; Schlegelberger B; Baum C
Leukemia; 2013 Apr; 27(5):1127-38. PubMed ID: 23212151
[TBL] [Abstract][Full Text] [Related]
18. UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation.
McGilvray R; Walker M; Bartholomew C
FEBS J; 2007 Aug; 274(15):3960-71. PubMed ID: 17635584
[TBL] [Abstract][Full Text] [Related]
19. Identification of translocational breakpoints within the intron region before the last coding exon (exon 12) of the EVI1 gene in two cases of CML-BC with inv(3)(q21q26).
Suzukawa K; Taki T; Abe T; Asoh H; Kamada N; Yokota J; Morishita K
Genomics; 1997 Jun; 42(2):356-60. PubMed ID: 9192861
[TBL] [Abstract][Full Text] [Related]
20. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.
Cuenco GM; Ren R
Oncogene; 2004 Jan; 23(2):569-79. PubMed ID: 14724585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
